Recombinant Insulin API Powder from Japan
Bulk active pharmaceutical ingredient powder of human insulin produced by recombinant E. coli or yeast. HTS 2937.12.00.00 for pure synthetic insulin substance before formulation into dosage forms.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Reference Drug Master File (DMF) with FDA; provide manufacturing process validation
• Lyophilized powder stable at 2-8°C; avoid freeze-thaw cycles in transit
• Bulk API declaration prevents erroneous Chapter 30 pharmaceutical classification